|
BAG2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.48180032080825E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.84229997923779E-09 |
| Normal-vs-Stage2 |
2.97540000415708E-08 |
| Normal-vs-Stage3 |
1.47969999997333E-06 |
| Normal-vs-Stage4 |
3.626300E-02 |
| Stage1-vs-Stage2 |
9.151800E-01 |
| Stage1-vs-Stage3 |
1.343010E-01 |
| Stage1-vs-Stage4 |
1.149730E-02 |
| Stage2-vs-Stage3 |
1.990040E-01 |
| Stage2-vs-Stage4 |
1.704400E-02 |
| Stage3-vs-Stage4 |
1.234240E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.38089572899025E-11 |
| Normal-vs-AfricanAmerican |
1.919560E-03 |
| Normal-vs-Asian |
2.436400E-01 |
| Caucasian-vs-AfricanAmerican |
3.761200E-01 |
| Caucasian-vs-Asian |
3.002400E-01 |
| AfricanAmerican-vs-Asian |
6.688400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.17100001812065E-09 |
| Normal-vs-Female |
5.96060001356591E-09 |
| Male-vs-Female |
7.754600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.722200E-03 |
| Normal-vs-Age(41-60Yrs) |
4.22589999660161E-08 |
| Normal-vs-Age(61-80Yrs) |
3.3331004622994E-10 |
| Normal-vs-Age(81-100Yrs) |
7.962100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.871800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.296600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.332400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.896400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.279200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.034600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.027700E-04 |
| Normal-vs-Grade 2 |
1.94479998771868E-09 |
| Normal-vs-Grade 3 |
3.78249997989855E-09 |
| Normal-vs-Grade 4 |
1.088770E-01 |
| Grade 1-vs-Grade 2 |
2.823800E-01 |
| Grade 1-vs-Grade 3 |
2.747800E-01 |
| Grade 1-vs-Grade 4 |
3.664400E-03 |
| Grade 2-vs-Grade 3 |
3.819200E-01 |
| Grade 2-vs-Grade 4 |
1.361030E-03 |
| Grade 3-vs-Grade 4 |
6.636200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.10209627482527E-12 |
| Normal-vs-ccB subtype |
2.155800E-03 |
| ccA subtype-vs-ccB subtype |
2.5613955401127E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.68519997956196E-09 |
| Normal-vs-N1 |
2.758600E-01 |
| N0-vs-N1 |
5.324200E-02 |
|
|
